China FDA To Blacklist Drug Makers With 'Low Credibility'
This article was originally published in PharmAsia News
Executive Summary
The China FDA said it plans to strengthen its oversight of drug manufacturers considered to have "seriously low credibility," including through more and stronger inspections.